CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.950
-0.130 (-3.19%)
At close: Dec 5, 2025, 4:00 PM EST
4.070
+0.120 (3.04%)
After-hours: Dec 5, 2025, 6:40 PM EST
CytomX Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 28.02 | 31.87 | -0.57 | -99.32 | -115.87 | -64.82 | |
| Depreciation & Amortization | 1.28 | 1.77 | 2.18 | 2.44 | 2.71 | 2.57 | |
| Asset Writedown & Restructuring Costs | 0.11 | 0.11 | - | 0.25 | - | - | |
| Loss (Gain) From Sale of Investments | -2.27 | -5.31 | -7.42 | -0.05 | 0.27 | -0.24 | |
| Stock-Based Compensation | 6.71 | 7.67 | 8.56 | 13.13 | 13.17 | 14.79 | |
| Other Operating Activities | 4.38 | 4.08 | 3.73 | 3.41 | 3.13 | 2.89 | |
| Change in Accounts Receivable | 1.72 | 0.33 | 32.55 | -35.2 | 0.01 | -0.79 | |
| Change in Accounts Payable | -0.7 | -0.3 | -1.43 | 0.07 | -0.14 | -0.86 | |
| Change in Unearned Revenue | -101.7 | -118.25 | -89.01 | 16.57 | -33.95 | 62.83 | |
| Change in Other Net Operating Assets | -9.79 | -8.2 | -4.63 | -12.09 | 11.64 | -11.12 | |
| Operating Cash Flow | -72.25 | -86.23 | -56.04 | -110.79 | -119.03 | 5.26 | |
| Capital Expenditures | -0.1 | -0.31 | -0.84 | -1.74 | -1.61 | -2.31 | |
| Investment in Securities | -30.09 | 100.01 | -149.83 | 100 | 24.1 | -16.41 | |
| Investing Cash Flow | -30.19 | 99.7 | -150.67 | 98.26 | 22.49 | -18.72 | |
| Issuance of Common Stock | 96.05 | 7.52 | 0.56 | 0.65 | 110.21 | 16.89 | |
| Other Financing Activities | - | - | 29.67 | - | - | - | |
| Financing Cash Flow | 96.05 | 7.52 | 30.23 | 0.65 | 110.21 | 16.89 | |
| Net Cash Flow | -6.39 | 20.99 | -176.48 | -11.88 | 13.67 | 3.43 | |
| Free Cash Flow | -72.35 | -86.54 | -56.88 | -112.53 | -120.64 | 2.95 | |
| Free Cash Flow Margin | -63.67% | -62.66% | -56.19% | -211.67% | -323.33% | 4.31% | |
| Free Cash Flow Per Share | -0.61 | -1.02 | -0.77 | -1.71 | -1.88 | 0.06 | |
| Levered Free Cash Flow | -55.38 | -44.2 | 43.66 | -8.92 | -46.11 | -53.86 | |
| Unlevered Free Cash Flow | -55.38 | -44.2 | 43.66 | -8.92 | -46.11 | -53.86 | |
| Change in Working Capital | -110.47 | -126.42 | -62.51 | -30.65 | -22.44 | 50.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.